Friday 30 March 2018

Population Health Management Market: Rise in Adoption of Health Care IT Tools to Fuel the Market

Transparency Market Research (TMR) has published a new report titled, “Population Health Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global population health management market was valued at US$ 118,500.0 Mn in 2016 and is projected to expand at a CAGR of 16.1% from 2017 to 2025. Rise in demand for innovative technologies and adoption of health care IT tools is anticipated to fuel the growth of the global population health management market from 2017 to 2025. North America and Europe are expected to dominate the global market owing to implementation of the Affordable Act in the U.S. and increase in health care IT spending. Asia Pacific is projected to be the fastest growing market by 2025. This is attributed to increase in medical tourism and adoption of population health management (PHM) tools in developed countries such as Japan and Australia. The market in Asia Pacific is likely to expand at a high CAGR of 17% from 2017 to 2025. Introduction of technologically advanced PHM tools by key players such as Cerner Corporation is likely to drive the global population health management market.


Benefits of PHM tools such as data integration, data analysis, care coordination, and reduction of health care cost have led to increase in adoption of PHM tools. Chronic diseases such as diabetes and cardiovascular diseases require identification of high risk patients and implementation of disease management. This is made possible by PHM tools. This is one of the factors projected to drive the global population health management market during the forecast period. Developed health care IT infrastructure and increase in health care IT spending are the other factors anticipated to propel the global market during the forecast period. Lack of awareness about PHM tools and application software is expected to restrain the global market from 2017 to 2025.

The report offers detailed segmentation of the global population health management market based on component, mode of operation, and end-user. In terms of component, the services segment is poised to account for the leading share of the global market during the forecast period from 2017 to 2025. Factors attributed to the higher share of the segment include services offered by PHM vendors such as data analysis guidance, end-user training, post-sale services, and maintenance of software. The segment is anticipated to hold about 40% share of the global market in terms of revenue in 2016. Based on mode of operation, the global market has been categorized into web-based, cloud-based, and on-premise. The web-based segment dominated the global market in 2016, accounting for over 40% share. The cloud-base segment is expected to grow at a rapid pace during the forecast period due to increase in adoption of cloud-based computing.

In terms of end-user, the global population health management market has been classified into health care providers, insurance providers, pharmaceutical companies, and others. The health care providers segment is expected to account for the largest share of the global market due to increase in use of PHM tools because of added advantages. The segment held approximately 40% share of the global market in 2016. The insurance providers segment held the second largest share of the market in 2016, attributed to advantages of PHM tools such as identification of high risk patients and hospitalized patients.


In terms of region, the global population health management has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the global market in 2016. The region is projected to dominate the global population health management market during the forecast period from 2017 to 2025. The market in North America is anticipated to expand at a CAGR of 15% to 16% from 2017 to 2025. Well-established health care infrastructure and strong support from public and private sectors in terms of reimbursement are attributed to the largest market share of North America. Rise in awareness about population health and government initiatives such as the Affordable Care Act are anticipated to drive the market during the forecast period. Europe is likely to hold the second largest share of the global population health management market. The market in the region is estimated to expand at a CAGR of 15% from 2017 to 2025. Increase in geriatric population, adoption of health care IT platforms, rise in chronic diseases, and surge in government initiatives to adopt health care IT propels the market in the region.

The population health management market in Asia Pacific is expected to witness exponential growth during the forecast period. Rise in disposable income, increase in geriatric population, high prevalence of chronic diseases, and initiatives by governments fuel the growth of the market in the region. Japan and Australia are the developed countries in the region, with high adoption of PHM platforms. The market in Latin America and Middle East & Africa is in a nascent stage. The market in these regions is likely to experience significant growth during the forecast period.
Major companies in the global population health management market include Koninklijke Philips N.V., Lumeris, Health Catalyst, McKesson Corporation, Cerner Corporation, ZeOmega, Healthagen LLC, UnitedHealth Group, International Business Machines Corporation, and Persivia.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Fluid Management Market: Increasing Adoption of Intravenous Infusion Therapy to Boost the Market

The global fluid management market is projected to reach over US$ 64 Bn by 2025, with a cumulative annual growth rate (CAGR) of over 5.3% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled ‘Global Fluid Management Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025.’ North America is expected to continue to be at the forefront of global demand, with the market in the region anticipated to expand at over 4% during the forecast period. This is due to increase in the incidence and prevalence of infectious and lifestyle diseases, rise in the number of end-stage renal disease (ESRD) patients, and rise in prevalence of diabetes and hypertension, driving demand for dialysis treatment.


The report offers detailed segmentation of the global fluid management market based on product, application, and end-user. The infusion therapy products segment is estimated to hold leading market share in 2017 and is anticipated to expand steadily during the forecast period. The infusion therapy segment includes infusion devices such as infusion pumps and infusion systems; IV access devices such as accessories and disposables such as administration sets; and IV solutions and products such as frozen & liquid premixed medications, empty containers for compounding, and IV solutions. The renal product segment, which predominantly includes dialysis products, is expected to expand at a significant CAGR during the forecast period, owing to rise in prevalence of end-stage renal diseases and increase in number of dialysis centers worldwide. For instance, according to the National Kidney Foundation, more than 2.0 million people undergo treatment for dialysis or kidney transplantation to stay alive across the world.

The home care settings segment of the global fluid management market is expected to expand at a rapid pace during the forecast period owing to increase in research and development activities for the launch of products suitable for home care settings, rise in patient preference for home-based treatments, and lowest cost of the treatments performed at home as compared to hospitals or dialysis centers. For instance, Baxter, a leading player in the global fluid management market is focusing on new product developments suitable for home hemodialysis.

In terms of value, North America is likely to continue its dominance in the global fluid management market throughout the forecast period, owing to a high incidence rate of chronic kidney diseases in the region, high adoption of dialysis procedures, rise in new product launches, and the rise in per capita health care spending in the region. For instance, according to national Institute of Diabetes and Kidney Diseases, in 2016, more than 661,000 Americans were suffering from chronic kidney failure, among these, 468,000 individuals were on dialysis and around 193,000 underwent kidney transplant. Europe is a prominent region of the global fluid management market, owing to the presence of a large number of pharmaceutical and medical device companies and increasing prevalence of lifestyle diseases such as obesity, diabetes, end-stage renal diseases, high blood pressure, and cancer among the population.


Asia Pacific is an emerging region of the fluid management market and is expected to expand at a rapid CAGR during the forecast perios, owing to a rapidly expanding health care industry; growing economy; and rise in prevalence of infectious and lifestyle diseases such as cardiac disorders, kidney diseases, and others, which are fuelling demand for infusion, dialysis, and endoscopic surgery treatments. For instance, according to a report by LifeSciences Industry Research, by 2020, the global ESRD patients receiving hemodialysis treatment is expected to reach 4.2 million, out of which 1 million patients are likely to to be from China. The fluid management market in Latin America and Middle East & Africa is expected to expand at a rapid pace owing to expansion in economies of countries in the regions, rise in disease prevalence, increase in urbanization, rise in adoption of novel medical technologies, changing lifestyles, and increase in health care awareness among the population of the regions.

Major players operating in the global fluid management market include Baxter, Fresenius SE & Co. KGaA, Nikkiso, Co., Ltd., C.R. Bard, Inc., Olympus Corporation, Ecolab Inc., Medtronic, Zimmer Biomet, BD, Smith & Nephew, Hospira, Inc., Animas Corporation, B. Braun Holding GmbH & Co. KG, Cardinal Health Inc., Stryker, Boston Scientific Corporation, Karl Storz GmbH, Richard Wolf GmBH, Asahi Kasei Medical Co. Ltd., Coloplast Group, and NIPRO Medical Corporation. Other prominent players in the global fluid management market include AngioDynamics, Promed Group Co., Ltd, ICU Medical, Inc., CONTEC MEDICAL SYSTEMS CO.,LTD, SWS Hemodialysis Care Co.,Ltd., Dialifegroup.com, and Medica S.p.A. Leading players in the market are focusing on the service portfolio and geographic reach with the help of mergers and acquisitions, partnerships, and new products launches.


About Us 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

North America to Stay at Forefront of Global Proliferative Diabetic Retinopathy Market

Companies in the global proliferative diabetic retinopathy market are employing strategic initiatives that include product development, geographical expansion, acquisitions, and mergers. These strategies are likely to aid the market players in advancing their businesses and increasing their market footprint. For example, ThromboGenics initiated partnership with Novartis (Alcon) for assisting in commercialization and marketing activities of JETREA beyond the U.S.


On similar lines, Alimera initiated sales of ILLUVEN in the U.K. and Germany, in a bid to foray the European market. The initiative was primarily aimed at tapping new markets and boosting revenue generation of the company. A new report of Transparency Market Research has profiles key players making notable contribution to expansion of the global market for proliferative diabetic retinopathy, which include Pfizer, Inc., Genentech, Inc. (Roche Holdings), Merck KGaA, Allergan Plc, Santen Pharmaceutical Co., Ltd., Cipla, Ltd., Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Intas Pharmaceuticals Limited, and Novartis AG.

According to World Health Organization, number of people affected with diabetes has exceeded 400 Mn, in case of adults, in 2014. Additionally, global prevalence of diabetes doubled, rising at over 8% in adult population. The Department of Assistive and Rehabilitative Services (DARS) has reported that nearly 80% of the diabetic population was affected from diabetic retinopathy in 2013, with a notable portion of this percentile estimated to acquire the proliferative condition. These numbers are further poised to witness a rise in the years to come, driven by unhealthy consumption patterns and comfort-driven lifestyles of consumers worldwide. This will further have a robust impact on demand for treatment drugs apropos to proliferative diabetic retinopathy in the foreseeable future.


The report estimates the market to record a splendid rise over the forecast period 2017 to 2026. Nearly US$ 1,000 Mn worth of drugs for treatment of proliferative diabetic retinopathy are anticipated to be sold worldwide by 2026-end. Considered as a serious sight threatening ailment on account of long-term exposure to diabetes, diabetic retinopathy results into progressive retinal damage and affects retinal circulatory system. Extremity of the disease, which may lead to proliferative condition, determines the selection of effective therapeutic measure, thereby entailing requirement for intraocular injections, laser surgery, vitrectomy, or anti-VEGF drug prescriptions.

In terms of revenues, North America is likely to remain at the forefront of the global proliferative diabetic retinopathy, driven by supportive reimbursement policies offered by the government coupled with greater prevalence of diabetes in the region. Additionally, robust penetration of management drugs such as anti-VEGF drugs viz. Lucentis, Avastin, and Eylea, has further supported revenue generation from treatment of this disease in North America. Europe and Asia-Pacific excluding Japan are also likely to endure as significant revenue contributors to the global proliferative diabetic retinopathy market.


Anti-VEGF drugs are likely to remain preferred among various drug class utilized for treatment of proliferative diabetic retinopathy across the globe. Revenues from sales of anti-VEGF drugs are poised to reach approximately US$ 700 Mn by 2026-end. Although corticosteroids’ sales are expected to record an impressive expansion in the market, revenues from this drug class will continue to be sluggish.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Medical Waste Management Market: Increasing Medical Waste Generation Is Fueling Market Growth

This report studies the current as well as future prospects of the global medical waste management market. Stakeholders of this report include companies and intermediaries engaged in the medical waste management services as well as new entrants planning to enter this market.
This research study analyzes the global market for medical waste management in terms of revenue (US$ Mn). For the research, 2016 has been considered as the base year and 2015 as the historical year, while all forecasts have been provided from 2017 to 2025. The global medical waste management market has been studied on the basis of nature of waste, waste types, waste generator types, and types of services provided by the players operating in the global medical waste management market. The global medical waste management market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global medical waste management market for 2016. The report also provides detail company profiles of emerging market players operating in the global medical waste management market.


The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the demand for medical waste management services in the global market. These factors would aid the stakeholders in establishing a strong foothold in the global medical waste management market. Furthermore, the market overview section comprises key industry events, product overview, and market attractiveness analysis in the global medical waste management market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and countries to identify the most attractive market.

The global medical waste management market has been segmented based on nature of waste, waste types, waste generator types, types of services provided by the players, and by geography. In terms of nature of waste the global medical waste management market has been segmented into non-hazardous medical waste and hazardous medical waste. In terms of waste types, the global medical waste management market is segmented into sharps, infectious & pathological waste, radioactive waste, pharmaceutical waste, and non-infectious waste. In terms of waste generator types, the market is divided into large quantity medical waste generators and mid & small quantity medical waste generators. The large quantity medical waste generators includes two subsegmnets such as hospitals and pharmaceutical and biotechnological companies. The hospitals segment is further classified into public hospitals and private hospitals. The mid & small quantity medical waste generators segment is categorized into clinics and physician’s offices, retail pharmacies, ambulatory surgical centers & long term care centers, laboratories, academic and research institutes, blood banks, and others (veterinary, mortuary and autopsy centers, home healthcare, military & government, nursing homes, tattoo parlor). The laboratories segment is further classified into pathological laboratories and diagnostic laboratories.


Geographically, the global medical waste management market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S., Canada, Germany, France, U.K., Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, Brazil, Mexico, South Africa, Israel, and GCC countries have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the medical waste management market in various regions has been provided in this section.

The report provides a detailed outline/blueprint of the medical waste management market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players.

Major players operating in the global medical waste management market includes CLEAN HARBORS, INC., Stericycle, Waste Management, Inc., Republic Services, Inc., Sharps Compliance, Inc., Veolia, Daniels Health, US Ecology, Inc., BioMedical Waste Solutions, LLC., and BWS Incorporated. The emerging players in the global medical waste management market includes ALBA Services GmbH & Co. KG, SUEZ, GRP & Associates, Inc., among others.


About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Wound Healing Market: Technologically Advanced Wound Care Management to Fuel Market Growth

The global Wound Healing market was valued at approximately US$ 23.3 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 4.8% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Wound Healing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that increasing patient pool for chronic wounds is likely to spur the demand of wound healing products in the coming years (2017 to 2025). As key players introduce technologically advanced wound healing solutions in developed markets such a North America and Europe, these regions are likely to account for dominating share of the global wound healing market. Established presence & wide distribution networks of major players and growing market penetration of emerging players are likely to boost growth of Asia Pacific wound healing market at a CAGR of around 5.3% from 2017 to 2025.


According to the Centers of Disease Control (CDC) statistics, an estimated 450,000 – 500,000 patients suffer from burn injuries each year in the U.S. The direct costs of treatment of burn injuries in the U.S., was estimated to be around US$ 10.4 Bn. Wounds impose underappreciated burden on the population across the globe and they account for the majority of injuries related to skin. Rise in the prevalence of diabetes and obesity, and increasing adoption rate for wound care therapy devices in developed and emerging markets are likely to fuel the uptake of wound healing products by 2025. However, high price of newly launched and technologically advanced wound care products restricts their demand. Conventional wound healing products are preferred over technologically advanced costly dressings in the emerging economies, despite their slow healing process. The price sensitive market of developing nations thus restricts the growth of advanced wound management technologies, which in turn has attributed for devaluation of the market, thereby restraining growth of global wound healing market.

The report offers detailed segmentation of global Wound Healing market based on product, wound type, and gender. Among the product types studied, wound closure agents segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. Topical agents segment which comprises hemostatic agents, antimicrobials, wound cleansers, and others are likely to get boost from their ongoing R&D activities, in turn estimating highest number of new product launches in the near future. The wound closure agents segment is anticipated to lose its market share during the forecast period, and is expected to hold a share of 24.0% by 2025 from 28.1% in 2016. Availability of other advanced wound healing products with reduced risk of infection are factors likely to hamper the market share of this segment.


Among wound types, chronic wounds segment is projected to hold dominant share of global wound healing market during the forecast period and is likely to expand at CAGR of around 5.0% from 2017 to 2025. From chronic wounds, ulcers sub-segment is expected to lead the global wound healing market in terms of CAGR by 2025. As per the Agency for Healthcare Research & Quality (AHRQ), in U.S. US$ 9.0 Bn to US$ 11.0 Bn are spent on pressure ulcers by health care systems annually. Significant patient population, and availability of favorable reimbursement policies which are driving manufacturers’ focus on business expansion in advanced wound care products are projected to fuel this expansion. Significant economic burden of surgical site infections (SSI), and higher treatment costs associated with it is expected to propel the expansion of chronic wound segment during 2017-2025.

In case of women, especially in low and middle income countries, there is significant gap between reported and actual cases of diabetes and chronic wounds, which is anticipated to improve during forecast period. In terms of gender, women segment held 52.9% of global wound healing market share in terms of revenue. Initiatives such as Wound Awareness Week and other outreach programs are projected to increase the awareness in significant patient population.

In terms of value, North America was leading contributor in global wound healing market in 2016. As per the data published by ‘Wound Care Awareness Week–2017’, the annual cost (including direct as well as indirect costs) of treatment of all types of wounds incurred to health care systems in the U.S. is US$ 50.0 Bn, while the annual cost of amputations exceeds US$ 8.0 Bn. High prevalence of chronic wound in this region is imposing significant economic burden and is increasing demand for affordable care in the U.S., which in turn is driving the growth of wound healing market in North America. Healthcare spending in emerging markets such as China and India are rising, which is fueling the expansion of Asia Pacific wound healing market. Geographical expansion of international players to this region through distribution and licensing agreements with local distributors in the region are anticipated to propel the growth of Asia Pacific in global wound healing market at CAGR of 5.3% from 2017 to 2025. Regaining economic growth in Latin America countries such as Brazil is augmenting healthcare expenditure through rise in private health insurance, entry of international wound healing products manufacturers & health care providers in this region. It is one of the major factor for the estimated growth of Latin America during 2017-2025.


The report also provide profiles of leading players operating in global wound healing market include Smith & Nephew plc, Integra LifeSciences Corporation, B. Braun Melsungen AG, Mölnlycke Health Care AB, 3M Healthcare, Ethicon, Inc. (Johnson & Johnson), Hill-Rom Holdings, Inc., Cardinal Health, Acelity L.P., Inc., ConvaTec Inc., BSN medical (Svenska Cellulosa Aktiebolaget SCA), Coloplast Group, Medline Industries, Inc., Organogenesis Inc., and Hollister Incorporated. Expansion of wound healing portfolio by acquiring the wound healing platform of emerging players is a key strategy adopted by many key players.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

 Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Drug Discovery Informatics Market: Outsourced Informatics to Fuel Market Growth

The global drug discovery informatics market was valued approximately US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0% from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025, according to a new market report published by Transparency Market Research (TMR) titled “Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that the cost and time of drug discovery are reduced to a very large extent in comparison with the traditional drug discovery process are spur the demand of drug discovery informatics in the coming years (2017 to 2025). As key players introduce their drug discovery using informatics in developed markets such a North America and Western Europe, these regions are likely to account for dominating share of the global drug discovery informatics market. The increasing number of uses of the drug discovery informatics such as the scientists use it to communicate their ideas with their colleagues in computational chemistry, and biology to design small parallel libraries, and to conduct their own preliminary analysis of interactions between the ligand and receptor in emerging markets such as China and India is likely to boost growth of Asia Pacific drug discovery informatics market at a CAGR of around 20.0% from 2017 to 2025.


The rising laboratory informatics such as sharing, and searching of digital discovery information, and electronic lab notebook for the improved storage are driving the growth of the drug discovery informatics. The technological advancements in the drug discovery informatics that are employed by computational informatics are leading to developments in scientific innovation. The cost and time of drug discovery are reduced to a very large extent that drive the growth of the global drug discovery informatics market. However, there are only a few institutions and organizations in the world to train on drugs discovery informatics; moreover, the related experience is low in trained professionals, which in turn has attributed for devaluation of the market, there by restraining growth of global drug discovery informatics market.

The Global Drug Discovery Informatics Market is classified on the basis of product, mode, function, end-user, and region. Based on the product, the market is divided into development informatics, and discovery informatics. The discovery informatics segment dominated the market in terms of revenue in 2016, due to its cost benefits. Development informatics is anticipated to grow during the forecast period owing to the technological advancements in the development informatics. In terms of mode the market can be categorized into outsourced informatics, and in-house informatics. Outsourced informatics is estimated to dominate in terms of revenue in 2016 owing to the rise in collaborations and lead drug discovery projects between pharmaceutical companies, and IT market participants. In-house informatics is anticipated to grow in the coming years due to rise in the awareness regarding the time and cost benefits in the long run for the biotechnological and pharmaceutical companies.


Based on function the market can be classified into sequencing and target data analysis, docking, lead generation informatics, identification & validation informatics, molecular modeling, and others. Sequencing and target data analysis is estimated to dominate the market in 2016, owing to reduced cost of sequencing informatics. Molecular modeling segment is anticipated to grow during the forecast period owing to the increasing number of applications of small molecules in drug discovery. In terms of end-user the market can be divided into contract research organizations, pharmaceutical & biotechnology companies, and others. Contract research organizations (CROs) segment is estimated to dominate in 2016, owing to increasing number of CROs all over the world for drug discovery. Pharmaceutical and biotechnological companies segment is anticipated to grow during the forecast period owing to the long term time and cost benefits of the drug discovery informatics.

Geographically, the global drug discovery informatics market can be categorized into Latin America, Middle East & Africa, Asia Pacific, Europe, and North America. North America held the large market share in 2016, and is anticipated to dominate during the forecast period. The increasing technological advancements in the drug discovery informatics in the region is likely to augment the market of Drug Discovery Informatics in North America. Europe accounted for the second large market share in global drug discovery informatics market defibrillators in terms of revenue in 2016. Rising prevalence of the infectious diseases and cancerous diseases drive the growth in the region. Asia pacific is anticipated to grow at the fastest growth rate during the forecast period. This is attributed to high adoption of drug discovery informatics that has led to major share held by Asia Pacific in the global drug discovery informatics market. Moreover, a large pool of patients with infectious diseases and favorable government initiatives for the health care sector in countries such as Japan, Singapore, and Dubai are likely to present immense opportunities for growth of the market in the region in the next few years. Middle East & Africa and Latin America are expected to grow during the forecast period. Rising awareness regarding the drug discovery informatics in the regions is anticipated to grow the demand for the drug discovery informatics during the forecast period.
The report also provide profiles of leading players operating in global drug discovery informatics market include Charles River Laboratories International, Inc., Thermo Fisher Scientific, PerkinElmer Inc., Biogen Inc., Boehringer Ingelheim GmbH, Insilico Medicine, Inc., International Business Machines Corporation, Schrödinger, LLC, Albany Molecular Research Inc. (AMRI), and Certara, L.P. These players are adopting the growth strategies that increase their product offerings, strengthen their geographical reach, increase customer base and garner market share. For instance, Thermo Fisher Scientific, one of the global company that offers a wide range of bio-analytical, diagnostics, and laboratories products has in-house drug discovery informatics. Such in-house drug discovery informatics are anticipated to expand in the during the forecast period.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Chemiluminescence Immunoassay Analyzers Market: Growing Test Offerings to Fuel Market Growth

The global chemiluminescence immunoassay (CLIA) analyzers market was valued over US$ 4.4 Bn in 2016 and is projected to register cumulative annual growth rate (CAGR) of over 6.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Chemiluminescence Immunoassay (CLIA) Analyzers Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that rising demand for international accreditations and result comparability by using high-throughput automated immunoassays is spurring the growth of chemiluminescence immunoassay (CLIA) analyzers in coming years (2017 to 2025). The North America and Europe are projected to dominate the global chemiluminescence immunoassay (CLIA) analyzers market in the coming years owing to increase in manufacturer focus for business expansion in these regions. Players are continuously developing multiplexed assay platforms and entering into distribution agreements to fortify their footprints in the North American and European markets. Growing adoption of technologically advanced products manufactured by local manufacturers like Shenzhen New Industries Biomedical Engineering Co., Ltd. is likely to drive the Asia Pacific chemiluminescence immunoassay (CLIA) analyzers market. The Asia Pacific chemiluminescence immunoassay (CLIA) analyzers market is expected to witness CAGR of over 6.5% from 2017 to 2025.


The report offers detailed segmentation of global chemiluminescence immunoassay (CLIA) analyzers market based on product, application, and end-user. Among the product segment, reagents segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. Factors attributed to the higher share of the reagent segment in the global market include frequent replacements leading to increasing usage of reagents when compared to analyzer platforms. Automated analyzers segment is likely to register comparatively higher growth rate in terms of value in the global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period owing to continuous innovations in the product technologies by major market players.

Among applications, endocrine disorders segment is projected to hold dominant share of global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period and is likely to expand at CAGR more than 6.0% from 2017 to 2025. Major factors responsible for the dominance of this segment are continuous innovations in test offerings and wide product portfolio of major as well as local manufacturers. For instance, in January, 2017, the world's first assay to measure free vitamin D was introduced by Future Diagnostics Solutions and DIAsource Immunoassays SA (Anteo Group). Such continuous new product launches, along with exponentially rising patient base in developed as well as developing countries are likely to drive the segment between 2017 and 2025. According to the National Institute of Diabetes & Digestive and Kidney Diseases in the U.S., nearly 4.6% of the U.S. population suffers from hypothyroidism, which highlights the significant need for advanced testing methods to diagnose the endocrine disorder. Hepatitis and retrovirus segment, accounted for more than 10.0% share of global chemiluminescence immunoassay (CLIA) analyzers market in 2016, in terms of value. It is anticipated to have substantial growth and account for approximately 12.0% of market share by 2025.


In terms of value, North America is likely to continue its dominance in the global chemiluminescence immunoassay (CLIA) analyzers market throughout the forecast period, owing to significant average selling prices of automated chemiluminescence immunoassay analyzers, rising demand from physicians for technologically advanced diagnostic instruments with enhanced specificity and precision, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures in the region. Latin America and Middle East & Africa are relatively untapped markets having high growth potential. The governmental cap on prices of analyzers and group purchasing policies by major multispecialty hospital chains in this region is further increasing adoption of rental CLIA analyzers in these regions. Middle East & Africa chemiluminescence immunoassay (CLIA) analyzers market is characterized with significant population base demanding affordable care, and rise in governmental initiatives for early diagnosis of these chronic diseases. For instance, as per UNAIDS publication in 2016, nearly 65% of the world’s HIV infected population are present in this region.

The report also provide profiles of leading players operating in global chemiluminescence immunoassay (CLIA) analyzers market. F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, and Beckman Coulter, Inc. (Danaher) are major players operating in the market, offering products with proprietary technologies, such as F. Hoffmann-La Roche Ltd.’s products are manufactured using proprietary electrochemiluminescence technology, while Abbott’s CLIA analyzers are manufactured using the chemiluminescent microparticle immunoassay technology. DiaSorin S.p.A. and Shenzhen New Industries Biomedical Engineering Co., Ltd. are the other major players in the developed and developing countries, respectively. Expansion of tests offering in integrated digital diagnostics platform through partnerships to improve oncology and critical care treatment is a growing trend in global chemiluminescence immunoassay (CLIA) analyzers market. For instance, in January 2018, F. Hoffmann-La Roche Ltd. and GE Healthcare entered into strategic partnership to develop an industry-first digital platform, which will provide digital clinical decision support solutions in oncology and critical care treatment. Other prominent players in the global chemiluminescence immunoassay (CLIA) analyzers market include Sysmex Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics (a part of Carlyle Group), and Tosoh Corporation.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

 Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Addiction Treatment Market: Growing Abuse of Prescription Drug to Fuel Market Growth

Transparency Market Research (TMR) has published a new report titled “Addiction Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smoking cessation therapy are likely to spur demand for addiction treatment market in the near future (2017 to 2025). North America and Western Europe are likely to account for dominant share of the global addiction treatment market due to introduction of new drugs by key players. Government initiative to spread awareness about drug addiction in emerging markets such as China and India is likely to boost the addiction treatment market in Asia Pacific. The market in the region is anticipated to expand at a CAGR of around 7.0% from 2017 to 2025.


The report offers detailed segmentation of the global addiction treatment market based on treatment type, drug type, treatment center, and distribution channels. In terms of treatment type, the tobacco/nicotine addiction treatment segment accounts for a leading share of the global market during the forecast period. Higher share of the tobacco/nicotine addiction treatment segment is attributed to high adoption and wide availability of various over-the-counter nicotine replacement products used to combat tobacco and nicotine addiction. Opioid addiction treatment segment is likely to expand at a comparatively higher growth rate during the forecast period due to increase in usage of illicit drugs.

The report offers detailed segmentation of the global addiction treatment market based on drug type. The nicotine replacement products segment is poised to account for a leading share of the global market during the forecast period. Expansion of the segment is due to rise in the number of smokers across the globe and this has increased concerns about health risks for both smokers and passive smokers. The Varenicline drug segment is anticipated to lose market share during the forecast period due to side effects such as stomach pain, sleep disorder, and diarrhea. The segment accounted for market share of approximately 21.3% in 2016 and is expected to reach 21.2% by 2025.

Based on treatment center, the outpatient treatment segment is projected to hold a dominant share of global addiction market during the forecast period. It is likely to expand at a CAGR of more than 6.0% from 2017 to 2025. Outpatient treatment centers less restrictive and less expensive. These factors are likely to drive the segment during the forecast period. Additionally, in outpatient center, an addiction patient usually requires to spend less time in the center for treatment. This helps those who unable to give extended time for treatments. In terms of value, the inpatient treatment center segment accounted for more than 18.0% share of the global addiction treatment market in 2016. It is anticipated to account for approximately 19.0% share of the market by 2025.

Enquiry for discount on this report @ 
In terms of value, North America dominated the global addiction treatment market in 2016. Rise in awareness regarding different opioid treatment programs and increase in government initiatives to raise awareness about substance abuse, ill effects of drug, and importance of abuse treatment are propelling the addiction treatment market in North America. Rise in health care spending in emerging markets such as China and India is fueling the addiction treatment market in Asia Pacific. Economic growth in countries such as Brazil in Latin American is boosting health care expenditure through rise in private health insurance, entry of international drug manufacturers, and health care providers in the region. This is likely to propel the addiction treatment market in Latin America to expand at a CAGR of 7.1% from 2017 to 2025.

The report also provides profiles of leading players such as Allergan plc, GlaxoSmithKline plc, Purdue Pharma L.P., Mallinckrodt, Hikma Pharmaceuticals PLC, Orexo AB, and Reckitt Benckiser (Indivior PLC) that operate in the global addiction treatment market. Expansion of addiction treatment portfolio through improving existing drugs and developing new drug molecules is one of the key strategy adopted by many key players. Moreover, company’s focuses on strategic partnership to expand their business in various regions. For instance, recently, Orexo AB plans to launch Zuvsolv in new markets through its partner MundiPharma.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Thursday 29 March 2018

Cancer Cachexia Market to Proliferate at a CAGR of 4.90% Over the Period from 2017 to 2025

The global cancer cachexia market demonstrates a considerably high competition among the leading players, finds a new research report by Transparency Market Research (TMR). The key vendors of cancer cachexia treatment solutions, globally, are actively involving in partnerships, mergers, and acquisitions with clinical trial companies in a bid to strengthen their product portfolios. They are likely to focus more on technological upgrades and introducing new therapeutics based on appetite stimulation mechanism of action for the treatment of cancer cachexia in the near future, as it will be the new trend in this market. The key participants operating in this market are Æterna Zentaris Inc., Aphios Corp., Alder BioPharmaceuticals Inc., Eli Lilly and Co., Helsinn Group, GTx Inc., Merck & Co. Inc., Bristol-Myers Squibb Co., Novartis AG, and XBiotech Inc., states the research report.


According to the research report, the global market for cancer cachexia was worth US$1.63 bn in 2016. Research analyst at TMR expect the opportunity in this market to rise at a CAGR of 4.90% during the period from 2017 to 2025 and reach a value of US$2.51 bn by the end of the period of the forecast. Among the therapeutics available for the treatment of cancer cachexia, the demand for progestogens is comparatively higher and is expected to remain so over the next few years, thanks to their efficiency. Regionally, the market is led by North America. Researchers project this regional market to continue on the top in the near future on account of the rising awareness among people regarding cancer supportive care, notes the market study.

The increasing prevalence of cachexia, especially in industrialized regions, such as North America, Europe, and Japan, is the main factor behind the significant growth of the market for cancer cachexia, worldwide. According to an estimation, currently, cachexia affects around nine million patients, globally, which is round about 1% of overall patient-pool across the world. This factor is expected to create more opportunities for existing participants and players, looking to enter the market over the next few years.


The strong product pipeline is another important factor that will support the growth of this market in the near future. “With a promising clinical pipeline and imminent regulatory approvals, the global market for cancer cachexia is likely to report a substantial growth in the years to come, states the author of the research study.

Although the worldwide market for cancer cachexia points towards a thriving future; its growth trajectory will not be smooth enough. The stringent regulatory requirements and the long procedure for FDA approval may dissuade the manufacturers of cancer cachexia drugs from investing in this market over the forthcoming years, which, in turn, will impede the growth of this market in the long run, states the research report.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Medical Image Analysis Software Market Value to be Worth US$ 4,668.8 Million by 2024

Although the opportunities in the market for medical image analysis software will continue to progressively expand in the near future as a result of improving healthcare infrastructure across the world, the competitive landscape will also remain fragmented owing to increasing number of participating companies – notifies the analyst of a fresh business intelligence report by Transparency Market Research (TMR). There is a large pool of suppliers in the global medical image analysis software market and the end users have plenty of options to choose from. That being said, a handful of players do hold a position of strength over their competitors, such as Siemens Healthineers, GE Healthcare, Agfa-Gevaert N.V., Hologic Inc., Philips Healthcare, Pie Medical Imaging, Sciencesoft USA Corporation, and Toshiba Medical Systems Corporation. The prominence of these players is a result of their technologically advanced products.


For instance, Siemens Healthcare offers Syngo medical imaging software that makes analysis, storage, and sharing of diagnostic images an efficient clinical process. The software makes magnetic resonance and computed tomography results readily available to the caregivers. On the other hand, GE Healthcare offers CardEP, which is an integrated software for image analysis for the applications of electrophysiology and cardiovascular. The software makes it possible to display the process of heart anatomy and pulmonary veins, reformat them, and analyze as a 2D or 3D cardiac ST images. For the newer players to make a mark in this market, they will have to develop innovative technology to counter the technology and healthcare giants.

According to the evaluations of the TMR report, the global medical image analysis software market will attain a valuation of US$4,668.8 mn by the end of 2024, with the demand projected to proliferate at a CAGR of 8.34% during the forecast period of 2017 to 2024. The report has segmented the market for the software to analyze medical images on the basis of software type (standalone and integrated), imaging type (2D, 3D, and 4D), modality (radiographic imaging, ultrasound, PET, SPECT, MRI, and CT), application (orthopedic, neurology, cardiology, oncology, nephrology, gynecology, dental, and others), and end users (research and academic institutes, clinics, hospitals, diagnostic centers, and ambulatory surgical centers). Geographically, North America is highlighted as the region with maximum potential in terms of demand, although Europe and Asia Pacific are other two regions with similar lucrativeness.


The demand for the software that can efficiently analyze medical image is expanding on the back of the prevalence of several chronic diseases such as cancer and CVDs. Percentage of geriatric population is on the rise too, which is extending the demand for tools that can enhance assessment of diagnostic images and detect diseases at an early stage. In addition to that, advent of 4D imaging technique is expected to be a boon for the medical image analysis software market. The 4D imaging provides detailed information about temporal and spatial evolution of 3D blood flow with full volumetric coverage of any cardiac region. The 4D imaging in MRI is useful to assess blood flow parameters associated with markers of Doppler ultrasound and echocardiography. Hence, the 4D imaging is beneficial for the evaluation of cardiovascular diseases.

Similarly, the 4D ultrasound technique provides complete fetal assessment in prenatal condition including fetal face, grimacing, breathing movements, swallowing, mouthing, isolated eye blinking patterns, and direction of limbs. These all are more convincing results than 2D imaging or 3D imaging. With the use of 4D ultrasound technique, prenatal neurodevelopment problems such as ADHD, schizophrenia, epilepsy, and autism can also be detected.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)